Latest Operational Capacity News

ReNerve has appointed J4 Biologics as a second manufacturer for its Empliq range to meet growing hospital approvals and market demand, strengthening its supply chain and scaling production capacity.

Minbos Resources has drawn down the first US$4.8 million from its US$16 million loan facility with South Africa’s IDC, marking a key step forward for the Cabinda Phosphate Fertilizer Plant. The company has initiated orders for critical equipment and completed Phase-1 construction, with Phase-2 contracts expected soon.

Northern Star Resources acknowledges Elliott Investment Management's views and reiterates its focus on leadership succession, project milestones, and strategic corporate reviews.

EV Resources has locked in agreements covering more than 50% of its Tecomatlán Processing Plant's feedstock capacity through four non-binding MOUs, advancing its path to near-term antimony production amid global supply tightness.

GR Engineering Services has locked in a $110 million EPC contract with Brightstar Resources for the Laverton Processing Plant, reinforcing its leadership in Australian minerals processing projects.

Infratil posted an 11% rise in operational EBITDAF to NZ$989 million in FY26, fuelled by a record 555MW CDC data centre contract and a 170% EBITDAF jump at Longroad Energy. The company refined its portfolio with over NZ$600 million in divestments and secured a BBB+ credit rating, underpinning a strong FY27 outlook.

Hydrix Limited has launched the retail phase of its accelerated entitlement offer aiming to raise up to $8.18 million by issuing six new shares per existing share at $0.005 each, plus free options. The institutional component has closed, and retail shareholders have until 5 June to participate.

Turaco Gold has delivered strong drilling results at its Afema Gold Project, extending mineralisation and supporting resource growth ahead of the June 2026 Pre-Feasibility Study.

CDC Data Centres has landed Australia's largest-ever data centre contract, a 555MW deal with a US investment grade client that pushes its total contracted capacity beyond 1GW and is set to boost EBITDAF past A$1 billion in FY28.

Resonance Health upgrades its FY26 underlying EBITDA guidance to $2.6 million, driven by operational efficiencies and growth in its Software-as-Medical Devices segment, despite a slight revenue timing delay.

Percheron Therapeutics has secured $2.2 million through an entitlement offer to fund the next stage of its HMBD-002 oncology program, with manufacturing underway and key data presentations lined up at major cancer conferences.

Tivan Limited has added Major Michael Stone (Retd) to its Technical Advisory Group, leveraging his 25 years of Timor-Leste expertise to boost local engagement and strategic guidance for its copper-gold projects. This move bolsters Tivan’s in-country capabilities as it advances its Turiscai, Baucau, and Ossu exploration portfolio.